omniture
logo
Search
PHARMABCINE INC
Media Room

Latest News

rss

PharmAbcine to present the final data of Phase IIa rGBM trial at SNO 2020

DAEJEON, South Korea, Nov. 16, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced t...

2020-11-16 21:00 1403

PharmAbcine to participate at BIO-Europe 2020

DAEJEON, South Korea, Oct. 23, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) announced t...

2020-10-23 20:00 10363

PharmAbcine expands partnership with Samsung Biologics for PMC-403

DAEJEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered in...

2020-09-21 20:00 1721

PharmAbcine Unveils Olinvacimab's Positive Results from Phase Ib Combination Studies at KSMO 2020

DAEJEON, South Korea, Sept. 14, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) today anno...

2020-09-14 20:00 1679

PharmAbcine is presenting at the KSMO 2020

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical...

2020-09-02 21:00 2064

PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line

DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340ks), a biotech company ...

2020-09-02 21:00 1961

PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS

DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered int...

2020-08-18 21:00 8634

PharmAbcine signs a research collaboration agreement with Wuxi Shuangliang Biotechnology (SLBio) to evaluate a combination therapy to treat NSCLC

DAEJEON, South Korea, Aug. 3, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into...

2020-08-03 21:00 2062

PharmAbcine Signs Long-term Contract Manufacturing Organization Agreement for Olinvacimab with Binex

DAEJEON, South Korea, June 26, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340) (CEO: Jin-san Yoo), ...

2020-06-27 00:00 1812
PharmAbcine Signs Long-term Contract Manufacturing Organization Agreement for Olinvacimab with Binex

PharmAbcine execute an agreement with Thermo Fisher for the development and manufacturing of its next-generation immune checkpoint blockade, PMC-309 for Phase I

DAEJEON, South Korea, June 10, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered int...

2020-06-11 00:00 943

PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine's existing assets to non-oncology areas

DAEJEON, South Korea, June 3, 2020 /PRNewswire/ -- PharmAbcine (KOSDAQ: 208340), a clinical-stage b...

2020-06-04 00:00 1522
123